Sustainable pipeline of innovative immunotherapies.


Transforming drug discovery and development through single-cell analytics.

Publications & Posters

Peer-reviewed scientific publications and posters.

HiFiBiO Therapeutics is a pioneer of novel antibody drug discovery and development by leveraging single-cell analytics to treat cancer, autoimmune and infectious disorders. We are applying our innovative Drug Intelligent Science (DIS™) technology towards discovering stratification biomarkers to match high-quality therapeutics with each and every patient.